Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study.
作者信息
Bewersdorf Jan Philipp, Shimony Shai, Shallis Rory M, Liu Yiwen, Berton Guillaume, Schaefer Eva J, Zeidan Amer M, Goldberg Aaron, Stein Eytan, Marcucci Guido, Bystrom Rebecca P, Lindsley R Coleman, Chen Evan C, Ramos Jorge, Stein Anthony, Pullarkat Vinod, Aldoss Ibrahim, DeAngelo Daniel J, Neuberg Donna S, Stone Richard M, Garciaz Sylvain, Ball Brian, Stahl Maximilian
机构信息
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
出版信息
Am J Hematol. 2024 Aug;99(8):1640-1643. doi: 10.1002/ajh.27366. Epub 2024 May 15.
PMID:38751104
Abstract
摘要
Zotero 插件